Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study.

Rebecca Richards¹, William Lunt¹, Michael Whitman¹, Giulia Spaltro¹, Rachel Hall¹

¹Second Nature, London, United Kingdom.

Abstract

BACKGROUND: Obesity affects >890 million adults worldwide, and traditional lifestyle interventions often lack long-term success. While glucagonlike peptide-1 receptor agonists (GLP-1RAs) have shown strong weight loss outcomes, access to specialist care is limited by cost and capacity. OBJECTIVE: This study evaluated the effectiveness, feasibility, acceptability, and potential cost-effectiveness o…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.